We launched in 2021 with seed and Series A funding of $26.1M from Microsoft’s Venture Fund, Playground Global, OpenAI’s Sam Altman, YC, FoundersX Ventures, and other leading investors.

Our growing world-class team is based in our office and lab HQ in the Boston Seaport.

Select Investors and Partners

CEO, OpenAI

Founding Partner, Shunwei Capital

Accelerate Your AI Drug Discovery Journey

Learn About Our ITO™ Platform

Partner with us

Fill out the form to explore how we can work together.

Company

First Name

Last Name

Phone

Message

Sumbit Message

Oops! Something went wrong while submitting the form.

Message sent successfully

Thanks for reaching out. Our team has received your message and will be in touch shortly.

Or if you prefer, you can contact us directly at

bd@1910.ai

Copy to clipboard